Q3
LONG ANSWER
10M
★ High-yield
Classify lymphomas. Describe Hodgkin lymphoma and differentiate it from non-Hodgkin lymphoma.
Definition and Classification
Lymphomas are malignant neoplasms of lymphoid tissue, arising in lymph nodes or extranodal lymphoid tissue, and divided into hodgkin and non-hodgkin lymphoma.
Hodgkin Lymphoma
- Bimodal age distribution — a peak in young adults (15–35) and another after 50
- Arises in a single node or chain and spreads contiguously to adjacent groups — which is what makes it curable by radiotherapy
- The neoplastic cell is the REED–sternberg cell, which forms only a small minority of the tumour mass; the bulk is a reactive infiltrate of lymphocytes, eosinophils, plasma cells and histiocytes
The Reed–Sternberg cell
- Large cell with a bilobed or bi-nucleate nucleus, each with a prominent eosinophilic nucleolus surrounded by a clear halo — the "owl-eye" appearance
- Immunophenotype — CD15 and CD30 positive; CD45 and CD20 negative
- Derived from a germinal centre B cell that has lost its B cell programme
- Variants — lacunar cell (nodular sclerosis), popcorn or lymphohistiocytic cell (nodular lymphocyte predominant, which is CD20 positive and CD15/CD30 negative), and mummified cells
| Subtype | Frequency | Features | Prognosis |
|---|---|---|---|
| Nodular sclerosis | The commonest, 65–70% | Young women; mediastinal mass; broad collagen bands dividing the node into nodules; lacunar cells | Good |
| Mixed cellularity | 20–25% | Older men; abundant classical Reed–Sternberg cells in a mixed inflammatory background; associated with EBV and HIV | Intermediate |
| Lymphocyte rich | 5% | Few Reed–Sternberg cells | Very good |
| Lymphocyte depleted | Under 5% | Elderly, HIV; abundant Reed–Sternberg cells with few lymphocytes | Worst |
| Nodular lymphocyte predominant | 5% | Popcorn cells; CD20 positive; behaves like a B cell lymphoma | Good, but late relapses |
CLINICAL PEARL
The prognosis follows the lymphocyte count, not the Reed–Sternberg count. The more lymphocytes and the fewer neoplastic cells, the better the outcome — lymphocyte-rich does best and lymphocyte-depleted worst. The reactive infiltrate represents the host response, and its vigour predicts survival.
Non-hodgkin Lymphoma
- Far more heterogeneous — over 60 entities in the WHO classification; about 85% are of B cell origin
- Spreads non-contiguously and is often disseminated at presentation, with frequent marrow and extranodal involvement
- Extranodal sites — stomach (malt), skin, brain, testis, thyroid, Waldeyer ring
| Type | Genetics | Features |
|---|---|---|
| Diffuse large B cell lymphoma | Bcl-6, bcl-2, MYC rearrangements | The commonest NHL; aggressive but curable with R-chop |
| Follicular lymphoma | T(14;18) — bcl-2 overexpression | Indolent but incurable; cells accumulate because they do not die |
| Burkitt lymphoma | T(8;14) — MYC | "starry sky" appearance from tingible-body macrophages among sheets of blasts; the fastest growing human tumour; endemic African form affects the jaw and is EBV-associated; sporadic form affects the abdomen |
| Malt lymphoma | T(11;18) | Gastric; caused by helicobacter pylori and may regress on eradicating it |
| Mantle cell lymphoma | T(11;14) — cyclin D1 | Aggressive, poor prognosis |
| Adult T cell leukaemia/lymphoma | HTLV-1 | Skin lesions, hypercalcaemia, lytic bone lesions |
Hodgkin Compared with Non-hodgkin
| Feature | Hodgkin | Non-hodgkin |
|---|---|---|
| Spread | Contiguous and orderly | Non-contiguous, unpredictable |
| Stage at presentation | Often localised | Usually disseminated |
| Extranodal involvement | Uncommon | Common |
| Mesenteric nodes and Waldeyer ring | Rarely | Commonly |
| Marrow involvement | Uncommon | Common |
| B symptoms | Frequent | Less common |
| Diagnostic cell | Reed–Sternberg cell in a reactive background | Sheets of neoplastic lymphoid cells |
| Prognosis | Generally better — over 80% cure | Very variable |
Staging and B Symptoms
| Ann Arbor stage | Extent |
|---|---|
| I | One lymph node region |
| II | Two or more regions on the same side of the diaphragm |
| III | Regions on both sides of the diaphragm |
| IV | Diffuse extranodal involvement — marrow, liver, lung |
- Suffix A — no systemic symptoms; suffix B — B symptoms present: unexplained fever above 38°C, drenching night sweats, and weight loss of more than 10% in six months
- Suffix E — localised extranodal extension; S — splenic involvement
- PEL–ebstein fever — a cyclical fever over one to two weeks alternating with afebrile periods; characteristic of Hodgkin lymphoma though uncommon
- Alcohol-induced pain in involved nodes is rare but almost specific
Applied Aspects
- Diagnosis requires an excision biopsy of a whole node — fine needle aspiration and core biopsy are inadequate, because the architecture is essential to classification
- In India, tuberculous lymphadenitis is the chief differential of persistent lymphadenopathy, and must be excluded by staining and culture
- Late effects of cure are now a major concern — second malignancies (breast cancer after mantle radiotherapy, AML after alkylating agents), cardiac disease, hypothyroidism and infertility
- Fertility preservation must be discussed before treatment, since these are young patients with a high chance of cure
- Pet-CT is used for staging and for assessing response, and an early interim pet now guides how much treatment is given
- Rituximab (anti-CD20) transformed B cell NHL, and is the reason diffuse large B cell lymphoma is now curable in the majority
All questions in Haematology II: Leukaemias, Lymphomas & Haemostasis
- Q1Classify leukaemias. Describe the clinical features and laboratory diagnosis of acute leukaemia and differentiate AML from ALL. ★
- Q2Describe chronic myeloid leukaemia and chronic lymphocytic leukaemia with their clinical features and laboratory findings. ★
- Q3Classify lymphomas. Describe Hodgkin lymphoma and differentiate it from non-Hodgkin lymphoma. ★
- Q4Describe the clinical features, laboratory diagnosis and complications of multiple myeloma. ★
- Q5Describe the approach to a patient with a bleeding disorder. Interpret the coagulation screening tests and classify the causes of thrombocytopenia. ★
- SN1Describe immune thrombocytopenic purpura with its types, features and management. ★
- SN2Describe haemophilia with its genetics, clinical features and laboratory diagnosis. ★
- SN3Describe von Willebrand disease and differentiate it from haemophilia A. ★
- SN4Describe the Reed-Sternberg cell with its variants and immunophenotype. ★
- SN5Define leukaemoid reaction. Differentiate it from chronic myeloid leukaemia and add a note on the leucoerythroblastic reaction. ★
- SN6Describe the indications, sites and interpretation of bone marrow examination. ★
- SN7Describe the hazards of blood transfusion.